$KUSA
Kashin, Inc.

2024 Q4 Form 10-Q Financial Statement

#000168316824008632 Filed on December 11, 2024

View on sec.gov

Income Statement

Concept 2024 Q4
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.433K
YoY Change -83.29%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.433K
YoY Change -83.29%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 53.56M shares
Diluted Shares Outstanding 53.56M shares

Balance Sheet

Concept 2024 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $31.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $31.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets $31.00
Total Long-Term Assets
Total Assets
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $102.7K
YoY Change 23.71%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $102.7K
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$665.5K
YoY Change 5.54%
Common Stock $68.56K
YoY Change 28.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$102.7K
YoY Change
Total Liabilities & Shareholders Equity $31.00
YoY Change

Cashflow Statement

Concept 2024 Q4
OPERATING ACTIVITIES
Net Income -$1.433K
YoY Change -83.29%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89703-4934
dei City Area Code
CityAreaCode
(626)
dei Local Phone Number
LocalPhoneNumber
429-2780
us-gaap Revenues
Revenues
0 usd
CY2024Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
98572 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-11493 usd
dei Amendment Flag
AmendmentFlag
false
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
68560745 shares
CY2024Q4 us-gaap Cash
Cash
31 usd
CY2024Q2 us-gaap Cash
Cash
126 usd
CY2024Q4 us-gaap Assets Current
AssetsCurrent
31 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
126 usd
CY2024Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
23234 usd
CY2024Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
19832 usd
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-108637 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001467845
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-10-31
dei Entity File Number
EntityFileNumber
333-161240
dei Entity Registrant Name
EntityRegistrantName
Kashin, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-4711535
dei Entity Address Address Line1
EntityAddressAddressLine1
112 North Curry Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Carson City
CY2024Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
79451 usd
CY2024Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
78156 usd
CY2024Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2024Q4 us-gaap Liabilities Current
LiabilitiesCurrent
102685 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
97988 usd
CY2024Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
68560745 shares
CY2024Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68560745 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63560745 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63560745 shares
CY2024Q4 us-gaap Common Stock Value
CommonStockValue
68561 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
63561 usd
CY2024Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
494328 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
494303 usd
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-665543 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-655726 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
-102654 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-97862 usd
CY2024Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
126 usd
CY2024Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
120000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 usd
CY2024Q4 us-gaap Revenues
Revenues
0 usd
CY2023Q4 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
120000 usd
CY2024Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1433 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1774 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9817 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7804 usd
CY2024Q4 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
0 usd
CY2023Q4 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
6800 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
120000 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
31800 usd
CY2024Q4 us-gaap Operating Expenses
OperatingExpenses
1433 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
8574 usd
us-gaap Operating Expenses
OperatingExpenses
129817 usd
us-gaap Operating Expenses
OperatingExpenses
39604 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
-1433 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-8574 usd
us-gaap Net Income Loss
NetIncomeLoss
-9817 usd
us-gaap Net Income Loss
NetIncomeLoss
-39604 usd
CY2024Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2024Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2024Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53560745 shares
CY2024Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53560745 shares
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53560745 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53560745 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53560745 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53560745 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53560745 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53560745 shares
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-21884 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-33377 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-35021 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-43398 usd
CY2024 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
284 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-64748 usd
CY2024 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-97862 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
25 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-8384 usd
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-101221 usd
CY2024Q4 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
0 usd
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
-1433 usd
CY2024Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
-102654 usd
us-gaap Net Income Loss
NetIncomeLoss
-9817 usd
us-gaap Net Income Loss
NetIncomeLoss
-39604 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
KUSA Expenses Paid On Companys Behalf By Related Party
ExpensesPaidOnCompanysBehalfByRelatedParty
1295 usd
KUSA Expenses Paid On Companys Behalf By Related Party
ExpensesPaidOnCompanysBehalfByRelatedParty
34590 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
3402 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
5014 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5120 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
25 usd
us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5025 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-95 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
126 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2024Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
KUSA Common Stock Issued In Exchange Of Payable Assignmentsettlement
CommonStockIssuedInExchangeOfPayableAssignmentsettlement
0 usd
KUSA Common Stock Issued In Exchange Of Payable Assignmentsettlement
CommonStockIssuedInExchangeOfPayableAssignmentsettlement
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q4 KUSA Working Capital
WorkingCapital
-102564 usd
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-665543 usd
CY2024Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0 shares
CY2024Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
35000 usd
CY2024Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68560745 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63560745 shares
CY2024Q4 KUSA Due To Related Party
DueToRelatedParty
0 usd
CY2024Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-008632-index-headers.html Edgar Link pending
0001683168-24-008632-index.html Edgar Link pending
0001683168-24-008632.txt Edgar Link pending
0001683168-24-008632-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kashin_ex3101.htm Edgar Link pending
kashin_ex3201.htm Edgar Link pending
kashin_i10q-103124.htm Edgar Link pending
kusa-20241031.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
kusa-20241031_cal.xml Edgar Link unprocessable
kusa-20241031_def.xml Edgar Link unprocessable
kusa-20241031_lab.xml Edgar Link unprocessable
kusa-20241031_pre.xml Edgar Link unprocessable
kashin_i10q-103124_htm.xml Edgar Link completed
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending